


Ask a doctor about a prescription for DONEPEZIL VIATRIS 5 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Donepezil Viatris 5 mg Film-Coated Tablets EFG
Donepezil Hydrochloride
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet:
Donepezil Viatris contains the active substance donepezil hydrochloride, which belongs to a group of medications called acetylcholinesterase inhibitors. Donepezil hydrochloride increases the levels of a substance (acetylcholine) in the brain, involved in memory function, by reducing the breakdown of this substance.
It is used to treat the symptoms of dementia in people diagnosed with mild to moderately severe Alzheimer's disease.
The symptoms of the disease include increased memory loss, increased confusion, and changes in behavior. As a result, people with Alzheimer's disease have more difficulty performing normal daily activities.
Do not take Donepezil Viatris
Warnings and Precautions
Consult your doctor or pharmacist before starting to take donepezil if you have or have ever had any of the following conditions:
Children and Adolescents
Children and adolescents under 18 years of age should not take this medication.
Other Medications and Donepezil Viatris
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication, including those obtained without a prescription. In particular, inform your doctor or pharmacist if you are taking any of the following:
If you are going to undergo surgery, including dental surgery, where you will be administered anesthesia, inform your doctor, dentist, hospital staff, or anesthesiologist that you are taking this medication.
Taking Donepezil Viatris with Food and Alcohol
You should avoid drinking alcohol while being treated with this medication, as it may reduce the effect of donepezil.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, or plan to become pregnant, do not take this medication before consulting your doctor for advice. Donepezil should not be used during pregnancy unless clearly necessary.
Donepezil should not be used during breastfeeding.
Driving and Using Machines
Do not drive or operate tools or machines if you feel dizzy, sleepy, and have muscle cramps while taking this medication. Additionally, Alzheimer's disease may affect your ability to drive or operate machines, so you should not perform these activities unless your doctor tells you it is safe to do so.
Donepezil Viatris contains Lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the administration instructions of this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Tell your doctor the name of your caregiver. Your caregiver will help you take the medication as prescribed.
Adults
The recommended starting dose is 5 mg of donepezil once daily for at least one month. Your doctor may increase the dose to 10 mg of donepezil per day. The maximum recommended dose is 10 mg per day. If you experience an increase in side effects while taking the 10 mg per day dose, consult your doctor or pharmacist.
Use in Patients with Hepatic and Renal Impairment
Your doctor may need to adjust the dose in adults with mild to moderate liver disease. No dose adjustment is required if you have kidney problems.
Method of Administration:
Take donepezil orally with a glass of water at night before bedtime.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend taking donepezil in the morning.
Your doctor will advise you on how long to continue taking the tablets. You will need to visit your doctor regularly to review your treatment and assess your symptoms. You can take this medication with or without food.
If you take more Donepezil Viatris than you should
Do not take more than one tablet per day. Contact your doctor or the nearest hospital emergency department immediately if you take more tablets than you should. Bring the package and any remaining tablets to the hospital so the doctor knows what you have taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20. Bring the package and any remaining tablets with you.
If you take more donepezil than you should, you may experience symptoms such as nausea, vomiting, salivation, sweating, slow heart rate (bradycardia), low blood pressure (dizziness or fainting when standing), respiratory problems, loss of consciousness, seizures (attacks). You may also experience an increase in muscle weakness, which can be life-threatening when respiratory muscles are involved.
If you forget to take Donepezil Viatris
If you forget to take a dose, take only one dose the next day at the usual time. Do not take a double dose to make up for forgotten doses.
If you forget to take the medication for more than one week, consult your doctor before taking the medication again.
If you stop taking Donepezil Viatris
When treatment is stopped, the beneficial effects of donepezil will gradually decrease.
Do not stop taking the medication without consulting your doctor first.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Inform your doctor or go to the nearest hospital emergency department immediately if you experience any of the following side effects:
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very Rare(may affect up to 1 in 10,000 people):
Frequency Not Known(cannot be estimated from available data)
Other Side Effects Include:
Very Common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Rare(may affect up to 1 in 1,000 people):
Frequency Not Known(cannot be estimated from available data)
Pisa syndrome (a condition that involves involuntary muscle contraction with abnormal flexion of the body and head to one side).
Reporting Side Effects:
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the package after EXP. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medications you no longer need. This will help protect the environment.
Composition of Donepezil Viatris
Tablet coating: hypromellose, titanium dioxide (E-171), and macrogol 400.
Appearance of the Product and Package Size
Your medication is presented in the form of film-coated tablets, round, white, marked with "DL" over a "5" on one side and "G" on the reverse.
It is available in package sizes of: 7, 10, 28, 30, 56, 60, 84, 98, 100 film-coated tablets, calendar packs of 28 and 98, and unit-dose blister packs of 50 x 1.
It is also available in bottles containing 100 and 250 film-coated tablets.
Not all package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
Mylan Hungary Kft.
Mylan utca 1
H-2900 Komárom
Hungary
You can request more information about this medication from the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medication is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Spain Donepezil Viatris 5 mg film-coated tablets EFG
France DONEPEZIL MYLAN 5 mg, film-coated tablet
Greece DONEPEZIL/MYLAN
Ireland Aripil 5 mg Film-coated Tablets
Italy DONEPEZIL MYLAN GENERICS
Poland Pamigen
Portugal Donepezil Mylan
United Kingdom (NI) Donepezil Hydrochloride 5 mg Film-coated Tablets
Czech Republic Donepezil Mylan 5 mg
Sweden Donepezil Mylan
Date of the last revision of this package leaflet:April 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DONEPEZIL VIATRIS 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.